Skip to content Skip to sidebar Skip to footer

Addressing Outbreaks of Norovirus and Avian Influenza: A Guide for Infection Prevention Professionals in Healthcare Settings

Within healthcare settings, the recent surges in norovirus and avian influenza (H5N1) outbreaks have spotlighted the significance of infection prevention practices. As a specialist in infection prevention, your role is pivotal in initiating proactive measures to protect health care workers, patients, and the wider community. This article provides an in-depth look at the salient facets…

Read more

Combating the ‘Quad-demic’: How Hospitals Can Cope with a Four-Virus Surge

As an infection prevention professional, you need to be at the forefront of dealing with the 'quad-demic' that is currently bombarding the United States. According to the latest reports from the Centers for Disease Control and Prevention (CDC), a simultaneous rise in the occurrence of three respiratory pathogens, COVID-19, flu, and RSVand, alongside the gastrointestinal…

Read more

Anticipating the ‘Quad-demic’: Rising Norovirus Cases Compound Seasonal Illness Risks

As winter advances, healthcare officials are becoming increasingly concerned not only about the expected regular influx of upper respiratory illnesses, such as respiratory syncytial virus (RSV), COVID-19 and flu, but also a notable spike in norovirus cases. This surge in contagious illnesses has sparked warnings about the onset of a possible 'quad-demic'. Dr. Joseph Aracri, chair…

Read more

Norovirus Outbreaks Prompt Ward Closures at Nottinghamshire Hospital: A Prevention and Management Strategy

King's Mill Hospital, located in Sutton-in-Ashfield, Nottinghamshire, experienced a wave of norovirus, commonly referred to as the 'winter vomiting bug,' prompting the closure of multiple wards. This highly infectious disease initially affected nine patients, necessitating the immediate shutdown of the first ward last Wednesday. While this ward was later reopened, the hospital had to close…

Read more

Advancements in Infection Prevention: The Promising Role of VXA-GI.1-NN in Combatting Norovirus

In his recent presentation at IDWeek 2024, Sean N. Tucker, PhD, Chief Scientific Officer and Vice President of Research at Vaxart, unveiled promising clinical trial results regarding VXA-GI.1-NN, a potential breakthrough in the prevention of Norovirus infections. Norovirus is a significant global health concern, known as a leading cause of acute gastroenteritis. Yet, the healthcare…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]